Hematology Update
April 8-9, 2017

Presented by Seattle Cancer Care Alliance

Course Description

This two-day program will cover evidence-based guidelines, recommendations and recent advances regarding therapeutic options for patients with benign and malignant hematologic disorders. At the end of the course, physicians will leave with a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for common benign and malignant hematologic disorders.

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top